Montreuil, France

Thomas Vazquez

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Vazquez: Innovator in Immunotherapy

Introduction

Thomas Vazquez is a notable inventor based in Montreuil, France. He has made significant contributions to the field of immunotherapy, particularly in the treatment of autoimmune and inflammatory disorders. His innovative approach combines interleukin-2 with an interleukin-1 inhibitor, showcasing his commitment to advancing medical science.

Latest Patents

Thomas Vazquez holds a patent for a groundbreaking invention titled "Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof." This patent relates to a combination of interleukin-2 (IL-2) and an interleukin-1 (IL-1) inhibitor, aimed at treating autoimmune and inflammatory disorders in subjects. The invention also includes a pharmaceutical composition comprising IL-2 and an IL-1 inhibitor, as well as a conjugate that features IL-2 conjugated to an IL-1 inhibitor. He has 1 patent to his name.

Career Highlights

Throughout his career, Thomas has worked with prominent organizations, including Iltoo Pharma and Sorbonne Université. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his research and development efforts.

Collaborations

Thomas Vazquez has collaborated with notable colleagues such as David Klatzmann and Jérémie Mariau. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

In summary, Thomas Vazquez is a distinguished inventor whose work in immunotherapy has the potential to transform the treatment of autoimmune and inflammatory disorders. His innovative patent and collaborations with esteemed professionals highlight his significant contributions to the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…